RTL
SAGE

Red Tortoise LLC’s Sage Therapeutics SAGE Stock Holding History

Red Tortoise LLC’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-163
Closed -$1.18K – 609
2024
Q3 		$1.18K Hold
163
– – ﹤0.01% 545
2024
Q2 		$1.77K Buy
+163
New +$2.09K ﹤0.01% 536
2023
Q4 		– Sell
-190
Closed -$3.91K – 582
2023
Q3 		$3.91K Buy
+190
New +$5.49K ﹤0.01% 321

Other funds holding SAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Red Tortoise LLC's SAGE Position: Q4 2024 in Review

Red Tortoise LLC sold out of Sage Therapeutics (SAGE) in Q4 2024, closing a stake of 163 shares — an estimated $1.18K sold.

Red Tortoise LLC first reported a position in SAGE in Q3 2023 and held it in 3 quarters. The position peaked at $3.91K in Q3 2023. 177 funds tracked by Wall St. Rank hold SAGE as of Q4 2024.

  • Red Tortoise LLC reported no remaining Sage Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Red Tortoise LLC sold 163 Sage Therapeutics shares in Q4 2024, an estimated $1.18K.
  • Red Tortoise LLC first reported a position in Sage Therapeutics in Q3 2023 and held it in 3 quarters.
  • Red Tortoise LLC's Sage Therapeutics position peaked at $3.91K in Q3 2023.
  • 177 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2024.

Based on Red Tortoise LLC's 13F filing for Q4 2024, filed 24 Jan 2025.